Work

Impact of Crizotinib Treatment on Patient-Reported Symptoms and Quality of Life (QOL) in Advanced Alk-Positive Non-Small Cell Lung Cancer (NSCLC)

Year: 2012

Type: article

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)33882-5

Authors: F.H. Blackhall, T.L. Evans, J. Han, R. Salgia, D. Moro-Sibilot, S. Gettinger, L. Crino, K. Wilner, A. Reisman, S. Iyer

Institutions: Hôpital Larrey, The Christie Hospital, The Christie NHS Foundation Trust, Centre Hospitalier Universitaire Vaudois, Centre Hospitalier Universitaire de Lille, National Cancer Center, Inserm, Institut Gustave Roussy, University of Chicago, Hôpital Albert Michallon, Yale University, Hôpitaux Universitaires de Strasbourg, Azienda Ospedaliera di Perugia, Centre Hospitalier Universitaire d'Angers, Pfizer (United States), Luzerner Kantonsspital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2181875635

FWCI: 1.545

Cites:

Cited by: 6

Related to: 10